Dare Bioscience Analyst Ratings
Dare Bioscience Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/10/2023 | 1570.38% | HC Wainwright & Co. | $7 → $6 | Maintains | Buy |
08/11/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
07/13/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
06/06/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
05/22/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
05/12/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
03/31/2023 | 1848.78% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
12/13/2022 | 1848.78% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
12/01/2022 | 1570.38% | JonesTrading | → $6 | Initiates Coverage On | → Buy |
04/01/2022 | 1570.38% | HC Wainwright & Co. | $5 → $6 | Maintains | Buy |
06/30/2021 | 2962.36% | Roth Capital | $9 → $11 | Maintains | Buy |
12/18/2020 | 1291.98% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
04/28/2020 | 1987.97% | Brookline Capital | → $7.5 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
---|---|---|---|---|---|
11/10/2023 | 1570.38% | HC Wainwright & Co. | 7 美元 → 6 美元 | 维护 | 买 |
08/11/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | 购买 → 购买 |
07/13/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | 购买 → 购买 |
06/06/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | → 购买 |
05/22/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | 购买 → 购买 |
05/12/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | 购买 → 购买 |
03/31/2023 | 1848.78% | HC Wainwright & Co. | → 7 美元 | 重申 | → 购买 |
12/13/2022 | 1848.78% | HC Wainwright & Co. | 6 美元 → 7 美元 | 维护 | 买 |
2022 年 1 月 12 日 | 1570.38% | JonesTrading | → 6 美元 | 启动覆盖范围开启 | → 购买 |
04/01/2022 | 1570.38% | HC Wainwright & Co. | 5 美元 → 6 美元 | 维护 | 买 |
2021 年 6 月 30 日 | 2962.36% | 罗斯资本 | 9 美元 → 11 美元 | 维护 | 买 |
2020 年 12 月 18 日 | 1291.98% | HC Wainwright & Co. | → 5 美元 | 启动覆盖范围开启 | → 购买 |
04/28/2020 | 1987.97% | 布鲁克林资本 | → 7.5 美元 | 启动覆盖范围开启 | → 购买 |
What is the target price for Dare Bioscience (DARE)?
Dare Bioscience(DARE)的目标价格是多少?
The latest price target for Dare Bioscience (NASDAQ: DARE) was reported by HC Wainwright & Co. on November 10, 2023. The analyst firm set a price target for $6.00 expecting DARE to rise to within 12 months (a possible 1570.38% upside). 9 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年11月10日公布了戴尔生物科学(纳斯达克股票代码:DARE)的最新目标股价。该分析公司将目标股价定为6.00美元,预计DARE将在12个月内升至12个月内(可能上涨1570.38%)。去年有9家分析公司公布了评级。
What is the most recent analyst rating for Dare Bioscience (DARE)?
Dare Bioscience(DARE)的最新分析师评级是多少?
The latest analyst rating for Dare Bioscience (NASDAQ: DARE) was provided by HC Wainwright & Co., and Dare Bioscience maintained their buy rating.
Dare Bioscience(纳斯达克股票代码:DARE)的最新分析师评级由HC Wainwright & Co. 提供,Dare Bioscience维持买入评级。
When is the next analyst rating going to be posted or updated for Dare Bioscience (DARE)?
Dare Bioscience(DARE)的下一个分析师评级何时公布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dare Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dare Bioscience was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括浏览公开财务报表,与Dare Bioscience的高管和客户交谈,以及听取财报电话会议。大多数分析师每三个月做一次这样的评级,因此每家公司每年应该获得4次评级。Dare Bioscience的最新评级是在2023年11月10日发布的,因此您应该预计下一个评级将在2024年11月10日左右公布。
Is the Analyst Rating Dare Bioscience (DARE) correct?
分析师对 Dare Bioscience (DARE) 的评级正确吗?
While ratings are subjective and will change, the latest Dare Bioscience (DARE) rating was a maintained with a price target of $7.00 to $6.00. The current price Dare Bioscience (DARE) is trading at is $0.36, which is out of the analyst's predicted range.
尽管评级是主观的,并且会发生变化,但最新的戴尔生物科学(DARE)评级保持不变,目标股价为7.00美元至6.00美元。戴尔生物科学(DARE)目前的交易价格为0.36美元,超出了分析师的预期区间。